US Bancorp’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.9K | Buy |
3,056
+711
| +30% | +$12.3K | ﹤0.01% | 2755 |
|
|
2025
Q1 | $51.3K | Sell |
2,345
-878
| -27% | -$19.2K | ﹤0.01% | 2724 |
|
|
2024
Q4 | $103K | Buy |
3,223
+1,327
| +70% | +$42.3K | ﹤0.01% | 2384 |
|
|
2024
Q3 | $54.7K | Sell |
1,896
-983
| -34% | -$28.4K | ﹤0.01% | 2679 |
|
|
2024
Q2 | $110K | Sell |
2,879
-687
| -19% | -$26.4K | ﹤0.01% | 2286 |
|
|
2024
Q1 | $210K | Sell |
3,566
-274
| -7% | -$16.1K | ﹤0.01% | 1982 |
|
|
2023
Q4 | $230K | Sell |
3,840
-58
| -1% | -$3.47K | ﹤0.01% | 1933 |
|
|
2023
Q3 | $148K | Buy |
3,898
+2,564
| +192% | +$97.5K | ﹤0.01% | 1963 |
|
|
2023
Q2 | $122K | Buy |
1,334
+23
| +2% | +$2.1K | ﹤0.01% | 2081 |
|
|
2023
Q1 | $86.5K | Buy |
1,311
+597
| +84% | +$39.4K | ﹤0.01% | 2262 |
|
|
2022
Q4 | $36.9K | Sell |
714
-3,553
| -83% | -$184K | ﹤0.01% | 2683 |
|
|
2022
Q3 | $291K | Buy |
4,267
+3,902
| +1,069% | +$266K | ﹤0.01% | 1652 |
|
|
2022
Q2 | $17K | Sell |
365
-745
| -67% | -$34.7K | ﹤0.01% | 3117 |
|
|
2022
Q1 | $56K | Buy |
1,110
+884
| +391% | +$44.6K | ﹤0.01% | 2553 |
|
|
2021
Q4 | $11K | Sell |
226
-117
| -34% | -$5.7K | ﹤0.01% | 3356 |
|
|
2021
Q3 | $12K | Buy |
343
+203
| +145% | +$7.1K | ﹤0.01% | 3325 |
|
|
2021
Q2 | $9K | Buy |
140
+33
| +31% | +$2.12K | ﹤0.01% | 3400 |
|
|
2021
Q1 | $4K | Hold |
107
| – | – | ﹤0.01% | 3509 |
|
|
2020
Q4 | $6K | Buy |
107
+77
| +257% | +$4.32K | ﹤0.01% | 3305 |
|
|
2020
Q3 | $1K | Sell |
30
-43
| -59% | -$1.43K | ﹤0.01% | 3487 |
|
|
2020
Q2 | $2K | Buy |
+73
| New | +$2K | ﹤0.01% | 3399 |
|